The bactericidal/permeability-increasing protein (BPI), a potent element in host-defense against gram-negative bacteria and lipopolysaccharide.
about
Cyanobacterial lipopolysaccharides and human health - a reviewNovel antibacterial activity of β(2)-microglobulin in human amniotic fluidStructure of HBP, a multifunctional protein with a serine proteinase foldAntifungal peptides: novel therapeutic compounds against emerging pathogensBoth systemic and local lipopolysaccharide (LPS) burden are associated with knee OA severity and inflammationPlunc, a member of the secretory gland protein family, is up-regulated in nasal respiratory epithelium after olfactory bulbectomyPotential applications of N-terminal recombinant fragments of bactericidal/permeability-increasing protein in liver surgery.Kinetics of the interaction of endotoxin with polymyxin B and its analogs: a surface plasmon resonance analysis.Peptide-based Antifungal Therapies against Emerging Infections.Surface plasmon resonance studies resolve the enigmatic endotoxin neutralizing activity of polymyxin B.Lipopolyamines: novel antiendotoxin compounds that reduce mortality in experimental sepsis caused by gram-negative bacteria.Improving hematopoietic cell transplant outcomes in a new era of genomic researchIndividual and synergistic effects of rabbit granulocyte proteins on Escherichia coli.Endotoxemia: methods of detection and clinical correlatesAntimicrobial activity of PLUNC protects against Pseudomonas aeruginosa infection.Parental transfer of the antimicrobial protein LBP/BPI protects Biomphalaria glabrata eggs against oomycete infections.Potent CD14-mediated signalling of human leukocytes by Escherichia coli can be mediated by interaction of whole bacteria and host cells without extensive prior release of endotoxinGenetic variation in bactericidal/permeability-increasing protein influences the risk of developing rapid airflow decline after hematopoietic cell transplantation.Lysine substitutions convert a bacterial-agglutinating peptide into a bactericidal peptide that retains anti-lipopolysaccharide activity and low hemolytic activityA Teleost Bactericidal Permeability-Increasing Protein Kills Gram-Negative Bacteria, Modulates Innate Immune Response, and Enhances Resistance against Bacterial and Viral Infection.Evidence of a bactericidal permeability increasing protein in an invertebrate, the Crassostrea gigas Cg-BPI.Substrate Selectivity of Lysophospholipid Transporter LplT Involved in Membrane Phospholipid Remodeling in Escherichia coliAn opsonic function of the neutrophil bactericidal/permeability-increasing protein depends on both its N- and C-terminal domains.Hemopexin down-regulates LPS-induced proinflammatory cytokines from macrophages.Antimicrobial peptides of the oral cavity.The potential of cholesteryl ester transfer protein as a therapeutic target.Chasing a ghost?--Issues with the determination of circulating levels of endotoxin in human blood.Endotoxemia-menace, marker, or mistake?Bactericidal/permeability-increasing protein inhibits growth of a strain of Acholeplasma laidlawii and L forms of the gram-positive bacteria Staphylococcus aureus and Streptococcus pyogenes.Bactericidal/permeability-increasing protein prevents mucosal damage in an experimental rat model of chronic otitis media with effusion.Antimicrobial action of rabbit leukocyte CAP18(106-137).Release of tumor necrosis factor alpha and interleukin 6 during antibiotic killing of Escherichia coli in whole blood: influence of antibiotic class, antibiotic concentration, and presence of septic serum.Glycosphingolipids from Sphingomonas paucimobilis induce monokine production in human mononuclear cells.Clinical relevance of antibiotic-induced endotoxin release.Action of human group IIa secreted phospholipase A2 on cell membranes. Vesicle but not heparinoid binding determines rate of fatty acid release by exogenously added enzyme.The prevalence and clinical significance of alpha 1-antitrypsin deficiency (PiZ) and ANCA specificities (proteinase 3, BPI) in patients with ulcerative colitis.Neutrophil-derived Oxidants and Proteinases as Immunomodulatory Mediators in Inflammation.Molecular cloning and characterization of spurt, a human novel gene that is retinoic acid-inducible and encodes a secretory protein specific in upper respiratory tracts.Lipopolysaccharide (LPS)-binding proteins BPI and LBP form different types of complexes with LPS.Lipopolyamines as a therapeutic strategy in experimental Gram-negative bacterial sepsis.
P2860
Q21245821-37C443E4-9247-4AFE-A28E-BC3978C68A09Q24303609-5F7D4940-BA3B-4B6E-A0C8-BE61A50C162CQ27735437-A764BE5F-4E59-4073-8199-9ABF7F4FCAB3Q28369443-D2BE8FC5-1B70-4E57-A3A1-41983FD53CE5Q28389532-4CA8894F-AB09-4FDF-B6C6-21A62BF055C3Q28581605-F4EB1874-919B-42C2-AD95-805200FF0BD2Q33539885-BBF79C2D-863F-415E-8AA2-D35A9D8AAF68Q33856365-E6FE3E65-AF24-4C27-BA37-3E21C87EFF7AQ33862289-A9689170-7340-454D-93FA-D7CCB91B9B0CQ33876349-F2544BDE-E6EF-445D-B953-01BEE9EB681FQ33976703-058C5190-C99B-4FEC-B4F3-922D83AB701AQ34157754-AE73BD79-6C00-448F-A0A7-6E7A933C4D72Q34229105-42638B83-683D-4C85-8EE7-AC4C45B8395EQ34300796-98420A6F-E944-4E90-AC3C-109B9ABA2B42Q35058932-FCAB44DD-8238-4775-8319-DF92B1F40044Q35075111-D52DBAB8-25B8-4A37-BF86-3AC5202062A2Q35516570-9DCB0443-62C7-41AF-BB8B-82ECFFF20616Q35849483-B09DFF1D-A780-460B-82E7-8CA81C4A0DC7Q35973333-82DBC811-7081-4B00-970A-4DC7ECE7463FQ35997086-6A046B9A-51AA-4906-9286-FFC1859A4600Q36140806-4ECFD95C-0A87-4594-BDC9-F3BDAD731BBAQ36518255-58B444A4-B199-4090-85BD-45C1864702BAQ36603406-0462B6DB-D7BE-427B-8EB8-1D398E48F642Q37304848-E3BE3E48-956C-4072-977B-26F8D08C5DAAQ37624908-DF670562-82A5-4A0F-A2C3-E81D3651CE16Q38554684-D28F512A-1FCB-4A58-B9DD-25FFCBEBD2BBQ38687215-25A0B2B7-3D7B-44CD-98CF-AC6E8E989606Q38897447-57DE847E-0A0F-4DA2-9264-3348E1D26844Q39471806-CCDC5D0A-0799-467E-A2F9-E4C2B6C0CE95Q39515770-0735A25F-794D-47B3-A1F6-57AA91901F49Q39783820-290B8AA2-1030-44FC-818E-216453816044Q39822209-B595236F-C5E3-4BCF-A3E8-D5B51C507E63Q39822606-4DFAB2D1-2324-4008-A12E-C1C25AB906A7Q39867014-4BC5A73A-D3A3-4A9E-9297-B72FD3B172A0Q40993744-874E076B-08D4-479A-978A-67D40F995B8BQ41704772-DA42AE4C-8967-4F63-97E2-7A642228687DQ41891037-2BE47230-2999-4437-A77C-BA92CD973592Q42686992-8677CE34-AC41-44FC-890B-ED4DBF90A374Q43536172-E32E2A3B-4CA5-45A7-8149-1213CCFDB2C0Q43718687-7A581B6F-AC69-4973-BDB1-891DEDFACDF3
P2860
The bactericidal/permeability-increasing protein (BPI), a potent element in host-defense against gram-negative bacteria and lipopolysaccharide.
description
1993 nî lūn-bûn
@nan
1993年の論文
@ja
1993年学术文章
@wuu
1993年学术文章
@zh-cn
1993年学术文章
@zh-hans
1993年学术文章
@zh-my
1993年学术文章
@zh-sg
1993年學術文章
@yue
1993年學術文章
@zh
1993年學術文章
@zh-hant
name
The bactericidal/permeability- ...... cteria and lipopolysaccharide.
@en
type
label
The bactericidal/permeability- ...... cteria and lipopolysaccharide.
@en
prefLabel
The bactericidal/permeability- ...... cteria and lipopolysaccharide.
@en
P1433
P1476
The bactericidal/permeability- ...... acteria and lipopolysaccharide
@en
P2093
P304
P356
10.1016/S0171-2985(11)80354-2
P577
1993-04-01T00:00:00Z